Health data company expands in Stamford as demand grows for genetic research and personal medicine

Sema4, a health data research company, announced Thursday it opened a 70,000-square foot building in Stamford with more than 300 workers processing genomic tests, its third site in Connecticut to keep pace with growing demand for data-driven health care.

The Stamford laboratory complements Sema4 1/4 u2032s Branford lab that was expanded earlier this year and its headquarters, also in Stamford.

The new Sema4 lab replaces one in New York City, providing additional capacity to support genomic testing and expand digital health services. With its Stamford and Branford labs, Sema4 will increase its ability to provide health information across several thousand genetically identifiable diseases to patients.

Eric Schadt, founder and chief executive of Sema4, said the new Stamford site will be a hub for research and development for predictive modeling and information-driven testing.

In addition to lab employees, the Stamford facility also has capacity for 100 genetic counselors, bioinformatics specialists and support service staff. Sema4 has more than 500 employees in Connecticut across its two lab facilities and Stamford headquarters. Its workforce has quadrupled over the last three years.

Sema4 also maintains an office in New York City.

The company’s growth reflects rapid advances in personal medicine and genomics, which focuses on sequencing and analyzing an organism’s genome, the DNA content in a cell.

The state announced in 2018 a $6 million loan to Sema4 to move its New York City laboratory to Connecticut and create 400 jobs. “We were kind of busting at the seams,” Schadt said at the time.

In Connecticut, Sema4 is part of an expanding cluster of medical technology companies, such as Arvinas, a New Haven cancer pharmaceutical company, and the Guilford medical device company Butterfly Network.

Stephen Singer can be reached at [email protected]

———

©2020 The Hartford Courant (Hartford, Conn.)

Visit The Hartford Courant (Hartford, Conn.) at www.courant.com

Distributed by Tribune Content Agency, LLC.

Continue Reading

Source Article

Read more

Fitbit Versa 3 review: A happy medium of health features and fitness tracking

Like

  • Up to six days’ battery life
  • Bright, always-on AMOLED display
  • Advanced sleep tracking
  • Onboard GPS
  • Mic and speaker for text dictation

Don’t Like

  • Relies heavily on mobile app
  • Slow to sync
  • Health metrics are hard to find
  • Notification replies are Android-only

The Fitbit Versa 3 is Fitbit’s best smartwatch for most people. With an always-on display, built-in GPS, blood oxygen and temperature tracking during sleep, and a battery that lasts six days, the Versa 3 holds its own against some of its pricier competitors like the Apple Watch SE and even the Fitbit Sense. While you don’t get the stress tracker and FDA-cleared electrocardiogram (ECG or EKG) like the Sense, the rest of the Versa 3’s smartwatch and fitness features are similar. As an added bonus, the Versa 3 costs $100 less than the Sense.

Better design all-around 

The Versa 3 still has the same square-ish watch body and metal frame as its predecessor the Versa 2, but it now has a larger 1.58-inch AMOLED screen with slimmer bezels. It’s bright, crisp and easy to see in direct sunlight. It can stay always-on (as a toned-down version with fewer metrics displayed) to give you a quick glance at the time without moving your wrist. And since Fitbit supports third-party watch faces, you have hundreds of different options to choose from. 

Despite its aesthetic improvements, the touchscreen and Fitbit interface still aren’t as responsive as what you’d get on an Apple Watch or Galaxy Watch, which also have AMOLED screens. The Versa 3 lags a bit between swipes and takes a while to load apps and display information.

Instead of a physical button on the side of the watch like its predecessors, the Versa 3 now has an indented haptic side button. In theory, this works exactly like a real button, but the haptic feedback is nowhere near as satisfying as pressing a real button and it takes some getting used to. 

Fortunately, not all the design changes have a learning curve. Fitbit has also overhauled the strap mechanism on the Versa 3 and now all you have to do to swap out bands is press a button. It’s so much easier than previous models, which had a tiny, fiddly clasp.

fitbit-versa-3-perforated-charcoal-leather-crop-center-v2

Fitbit

Better training tools for fitness tracking

At this point it’s safe to assume most Fitbit devices can handle your basic fitness-tracking needs, measuring steps, distance, calories burned and heart rate. The Versa 3 covers the basics well and has the same fitness features as the more expensive Sense. It tracks 20 different activities including indoor and outdoor swimming and has automatic workout detection for some exercise types like running if you forget to start a session. 

It’s also the first Versa smartwatch to have built-in GPS, although not the first Fitbit, as the Charge 4 and Sense also have built-in GPS. As a runner, not having GPS on earlier Versa models

Read more

CGHS beneficiaries to avail health benefits of traditional medicine systems also

All CGHS beneficiaries—serving as well as pensioners— will now be able to avail the health benefits of alternate traditional systems  with the Union Health Ministry approving a proposal to empanel such Centres of Ayurveda, Yoga and Naturopathy under the Government health scheme.

“Private Day Care Therapy centers of Ayurveda, Yoga and Naturopathy will be empanelled under the CGHS shortly, in a manner similar to empanelment of similar day care centres of conventional (Allopathy) medicine already provided under the CGHS,” said an official from the Ministry.

Initial empanelment of  day care therapy centres will be undertaken on pilot basis for Delhi and NCR for a period of one year and subsequently would be considered for other places.

The official said that the step has been taken keeping in view of the growing popularity of AYUSH system of medicines amongst the public at large and all CGHS beneficiaries. The aim of the scheme is to improve the health and wellbeing, reduce health care expenditure and provide excellence in service delivery, efficiency, and comfort to the patients.

The treatment procedure requiring a short duration of stay in the Day Care Therapy Centre, ranging from a few hours to less than a Day will be made available to CGHS beneficiaries under this scheme.

“As the treatment procedure does not require overnight stay in the unfamiliar environment, it is extremely convenient for children and elderly patients,” said the official.

At present treatment of approved procedures like Panchkarma and Abhyanga etc. is given only after hospitalization in CGHS empanelment hospital.

Source Article

Read more

The 9 top health and medicine breakthroughs of 2020

Despite the upheaval the coronavirus pandemic has brought, uneasy times also set a course for innovation. Pharmaceutical companies have pivoted to vaccine development, while biotechnology laboratories at major corporations and universities have become laser-focused on developing accurate testing devices, including an easy-to-use, fast, reliable, and extremely cheap test for COVID-19; personal protective equipment, like a prototype for a reusable N95 mask; and technologies to ensure people have access to the best possible medical care during trying times. And in spite of these difficult days, better treatments for existing challenges such as myopia, migraines, sleep apnea, and acne have prevailed, helping this year’s top health advances provide the glimmer of hope we all need.



a screenshot of a video game remote control: The year's most important developments in the world of health.


© Provided by Popular Science
The year’s most important developments in the world of health.



The BinaxNOW COVID-19 test displays a positive result within 15 minutes.


© Provided by Popular Science
The BinaxNOW COVID-19 test displays a positive result within 15 minutes.

Grand Award Winner: BinaxNOW COVID-19 Ag Card rapid antigen test by Abbott Laboratories

A fast, ultra-cheap coronavirus test

Diagnostic tests to detect SARS-CoV-2, the virus that causes COVID-19, can take days to deliver results. But that limbo time between is crucial. Spotting the novel virus as early as possible can signal infectious people to isolate themselves, and help contact tracers identify and notify anyone they’ve been in close quarters with. Since March, countless new offerings to evaluate the population’s infection rates have hit clinics, but one rises above the rest: Abbott’s BinaxNOW rapid test, which received emergency-use authorization from the FDA in August. It detects COVID in fifteen minutes for around $5 per test—and without the need for specialized lab equipment.

To administer the test, a healthcare worker opens a card—which is about the size of a driver’s license—and adds a few drops of a liquid called a reagent. That solution contains chemicals that react with the SARS-Cov-2 nucleocapsid antigen, which is the most abundant coronavirus protein in infectious individuals. Then, using an included swab, the provider takes a nasal sample, inserts it into the card, and folds the paper. A positive result—displayed as two pink lines on the outside of the card—will become evident in about 15 minutes. The system correctly identifies patients with the novel virus 97.1 percent of the time, on average, and provides an accurate negative test 98.5 percent of the time, making it a reliable and speedy assessment of COVID-19.



a close up of a device: Aklief is the first novel retinoid cream in more than 20 years.


© Provided by Popular Science
Aklief is the first novel retinoid cream in more than 20 years.

Aklief cream by Galderma Laboratories, L.P.

A retinoid acne product that’s easier on your skin

Acne vulgaris (meaning “common”) affects up to 85 percent of teens and young adults in the US, according to a 2013 study in the British Journal of Dermatology. A regularly used group of medications called retinoids help alleviate the condition by binding to retinoic acid receptors (RAR) on the skin’s surface, which in turn stimulate and speed up cell growth, causing old cells to rapidly shed and give way to newer, healthier ones. But this process often leads

Read more

6 Best Fish for Brain Health, According to a Top MD

When I picture myself in my older years, I like to hope that my mind will be just as sharp as Sophia on Golden Girls. Sure, I still want to be able to go for walks around the neighborhood and get in on any shuffleboard games going on, but I definitely want my brain to still be strong, too. As with any health goal, preparing for the future means thinking in the present.

Functional medicine doctor Mark Hyman, MD is passionate about brain health, too. He talks about it a lot in his books, specifically focusing on how food can benefit brain health both in the immediate and long-term. And this week, he revealed his number one favorite brain-boosting food on Instagram. Can you guess what it is? Fish!

“Seafood is one of the best dietary sources of protein around, and it’s chock-full of nutrients like iodine, selenium, vitamin D, and B12,” Dr. Hyman wrote in the caption of his post. “But the biggest health benefits of fish comes from the two omega-3 fatty acids that we get from them and nowhere else.” He adds that these polyunsaturated fats—specifically DHA and EPA—are strongly linked to benefitting both the heart and the brain.  (Love a multitasking food.) “Large studies have found that omega-3 fats also protect you from type 2 diabetes, inflammation, autoimmune disease, and even depression,” Dr. Hyman adds.

Of course, there’s a lot of fish in the, er, sea so the next question becomes what type of fish to buy. Dr. Hyman’s favorites are sardines, anchovies, mackerel, herring, rainbow trout, and wild salmon—all of which have the highest amounts of DHA and EPA. He recommends minimizing the amount of tuna, swordfish, king mackerel, catfish, Chilean sea bass, and tilefish you consume because they tend to be higher in mercury.

It’s also important to consider sustainability when shopping for fish, and there are some helpful labels that can help. The main one to look for is the Marine Stewardship Council, which takes into account codes and guidelines provided by the UN Food and Agriculture Organization (FAO), ISEAL, and the Global Sustainable Seafood Initiative (GSSI). These standards require fisheries to combat overfishing, have a minimal impact on the environment, and other requirements.

Even if you’re not going grocery shopping as often, you can still stock up on brain-healthy fish by buying frozen seafood, which will last longer and also tends to be less expensive. “Fish can be even more nutritious when frozen,” registered dietitian Tracy Lockwood Beckerman, RD previously told Well+Good. This is because it’s typically frozen almost as soon as it’s caught, which preserves nutrients at their peak.

Will taking fish oil supplements give you the same benefits as eating seafood? Watch the video below to find out:



So next time you’re at the grocery store and want to fill your cart with something you know will benefit your brain, you know what to do: go fish.

Oh hi! You look like someone who loves free workouts,

Read more

How to Be Part of Men’s Health’s Next Major Virtual Health & Fitness Event

Men’s Health’s virtual event, MH Weekenders, is coming soon, and it’s going to be big.

We don’t want to give much away yet, but throughout the whole of January some of the world’s biggest and most respected athletes and personalities will be taking part. From Saturday night cook-alongs, to in-depth interviews and discussions as well group workouts and challenges to take part in, this festival has something for everyone.

We’re going big with this, and we want you to take part. This is your chance to reach out to our digital audience of over 5 million people.

This content is imported from YouTube. You may be able to find the same content in another format, or you may be able to find more information, at their web site.

What Are Men’s Health Virtual Events?

Unfortunately, getting together to get sweaty and debate the pressing issues in the world of health and fitness is not an option at the moment, which is why we’ve gone virtual.

Our events will take place over the last four weekends of January 2021 – Saturday 9th to Sunday January 31st – with each day comprising of four structured events that will be hosted on the Men’s Health YouTube channel. These videos will also be featured in digital articles and posted across menshealth.com/uk, Twitter, Facebook and Instagram.

The line-up will be announced in the coming weeks, so keep an eye out.

How You Can Get Involved

Of course, the line-up is not all we’re shouting about. We recognise that with such an event, this is a great opportunity for brands to showcase their products and services to our audience. So, we’ve devised a few new ways for you to reach them. Virtually, of course.

Register your brand

MH Weekenders Marketplace

The MH Weekenders Marketplace will offer businesses the chance to exhibit with us. On the final weekend of January, event attendees will be able to attend the online marketplace where they’ll be able to shop and receive discounts to their favourite health brands.

MH Weekenders E-Zine

As an event bonus, our registered attendees will receive our free e-zine ­– a digital event guide and marketplace electronic magazine, which will feature a selection of our favourite wellness brands.

If you’re a brand looking to get involved, sign up via the registration from below.

Register your brand


Sign up to the Men’s Health newsletter and kickstart your home body plan. Make positive steps to become healthier and mentally strong with all the best fitness, muscle-building and nutrition advice delivered to your inbox.

SIGN UP

For effective home workouts, uplifting stories, easy recipes and advice you can trust, subscribe to Men’s Health UK.

SUBSCRIBE

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

Source Article

Read more

Prescient Medicine Holdings is Now SOLVD Health

SOLVD Health will focus on the development and commercialization of its innovative technologies, which utilize machine learning and custom algorithms. These technologies include two groundbreaking tests, which have both been granted Breakthrough Device designations by the U.S. Food and Drug Administration (FDA). One is a genetic test designed to identify people at increased risk for opioid use disorder (OUD) prior to taking oral prescription opioids. The other test analyzes an individual’s microbiome and is designed to detect colorectal cancer and precancerous adenomas.

“At SOLVD Health, we aim to prevent people from becoming patients,” said Dr. Donaldson. “By providing contextualized insights before symptoms occur – a model that we call Patient Intelligence – we can improve patients’ lives while also changing how we think about and conduct healthcare as a society.”

To learn more, visit the new SOLVD Health website at www.solvdhealth.com.

About SOLVD Health
SOLVD Health is a privately held company focused on preventing disease and suffering by making contextual health information accessible to everyone. Through the development of insights-based health tools, we are enabling individuals and their providers to make better decisions about their health and the health of their families. We accomplish this by translating complex biological signals into actionable patient data that can point the way to better health. To learn more about us, our solutions, and our career opportunities, visit us on LinkedIn, Twitter, or at www.solvdhealth.com.

SOURCE SOLVD Health

Related Links

http://www.solvdhealth.com

Source Article

Read more

Farmmi Participates in Shanghai International Health, Wellness and Fitness Expo

LISHUI, China, Nov. 30, 2020 /PRNewswire/ — Farmmi, Inc. (“Farmmi” or the “Company”) (NASDAQ: FAMI), an agriculture products supplier in China, today announced its participation in the Shanghai International Health, Wellness and Fitness Expo (the “Expo”), which was held from November 25 to 27, 2020. The Expo, the largest of its kind in Asia, included edible fungi in its featured products.

The Expo covered a total exhibition area of 54,000 square meters, with 452 national and international brands, gathering 43,076 domestic and international buyers.

Ms. Yefang Zhang, Farmmi’s Chairwoman and CEO, commented, “While we have done an excellent job closing sales opportunities in the new virtual world of 2020, it was exciting for us to get back in front of customers and partners at the Expo. The organizers put necessary safety controls in place to ensure the health of attendees. We thank them for their efforts in making this such a successful expo for all participants.”

“With the improvement of living standards, people are becoming more particular about their health and diet. Farmmi is benefitting from inclusion and wider adoption of edible fungi, which are now a standard part of the new healthy diet structure. Low calorie bacteria with high protein, low fat and high efficacy are now recognized worldwide as nutritional, health foods,” continued Ms. Zhang. “As a leading agricultural products supplier, processor and retailer of Shiitake mushrooms, Mu Er mushrooms, other edible fungi, and many other sought-after agricultural products, Farmmi has the scale and strict controls to build upon customer demand growth worldwide.”

Ms. Zhang concluded, “The Expo, which emphasized technology and innovation, served as an important platform for our company to meet customers, promote products, carry out industry exchanges and seek cooperation opportunities. This is fully in-line with our strategy to seek out and execute on increased business opportunities in both the domestic China market and worldwide.”

About Farmmi, Inc.

Headquartered in Lishui, Zhejiang, Farmmi, Inc. (NASDAQ: FAMI), is a leading agricultural products supplier, processor and retailer of Shiitake mushrooms, Mu Er mushrooms, other edible fungi, and many other sought-after agricultural products. The Company’s Farmmi Liangpin Market serves as a trading platform for Chinese geographical indication agricultural products and is a large platform for consumers to access locally sourced agricultural products. For further information about the Company, please visit: http://ir.farmmi.com.cn/.

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including the potential impact of COVID-19 on our business within and outside of China. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,”

Read more

Ancient Aztec Medicine Could Be A Gamechanger For Mental Health

(MENAFN – Baystreet.ca) Thousands of years ago, ancient Aztecs may have held the https://www.ncmh.info/2020/03/30/mental-health-and-magic-mushrooms/ key to the next biotech breakthrough.

During ceremonial rituals, they used a special compound they called “the flesh of the gods”…

And today, researchers are discovering that this same compound could transform how we approach mental health moving forward…

Sparking an explosion of interest in what some experts project could be a https://www.openpr.com/news/2068844/psychedelic-drugs-market-2020-to-grow-at-16-3-cagr-by-2027 $6.9 billion market by 2027

It’s already being studied in some of the top medical facilities in the United States, including Johns Hopkins University…

Where it was found that this chemical was up to https://www.npr.org/sections/health-shots/2020/11/04/931377532/rigorous-study-backs-a-psychedelic-treatment-for-major-depression 4x more effective in treating depression than typical antidepressants.

Source: https://www.beckleyfoundation.org/2016/05/17/magic-mushrooms-psilocybin-a-breakthrough-treatment-for-depression-from-the-beckleyimperial-research-programme/ BeckleyFoundation.org

Now, the media is taking the story mainstream as it continues to gain steam by the day.

CNN reported “One use of [this compound] https://www.cnn.com/2020/01/28/health/magic-mushrooms-psilocybin-cancer-patients-study-wellness/index.html reduces anxiety and depression in cancer patients.”

Fortune Magazine reported “Psychedelic drugs may https://fortune.com/longform/psychedelic-drugs-business-mental-health/ revolutionize mental health care.”

And https://www.cnbc.com/2020/11/04/oregon-becomes-first-state-to-legalize-magic-mushrooms-as-more-states-ease-drug-laws.html CNBC is reporting “Oregon becomes first state to legalize [the special compound] as more states ease drug laws in https://www.cnbc.com/2020/11/04/oregon-becomes-first-state-to-legalize-magic-mushrooms-as-more-states-ease-drug-laws.html ‘psychedelic renaissance'”

This could become one of the greatest transformations in mental health care we’ve seen in decades, with the potential to treat chronic conditions much faster than typical treatments.

And one company plowing ahead at the forefront of this breakthrough is Lobe Sciences Ltd. ( https://finance.yahoo.com/quote/LOBE.CN?p=LOBE.CN & .tsrc=fin-srch CSE:LOBE ; https://finance.yahoo.com/quote/GTSIF?p=GTSIF & .tsrc=fin-srch OTC:GTSIF ).

Earlier this year, they acquired Eleusian Biosciences Corp., another growing biotech company with several provisional patents to their name.

Between the treatments they’ve identified and devices they’re in the process of developing, they have the potential to own a significant share of this booming market.

And at a market cap of just https://finance.yahoo.com/quote/LOBE.CN?p=LOBE.CN & .tsrc=fin-srch C$8 million, this could be a major boom for early investors as news continues to break in this fascinating field.

Here are 5 reasons why you should be paying attention to Lobe Sciences ( https://finance.yahoo.com/quote/LOBE.CN?p=LOBE.CN & .tsrc=fin-srch CSE:LOBE ; https://finance.yahoo.com/quote/GTSIF?p=GTSIF & .tsrc=fin-srch OTC:GTSIF ).

#1 – The Massive Mental Health Market

In 2019, it was estimated that https://www.nimh.nih.gov/health/statistics/mental-illness.shtml#:~:text=Mental%20illnesses%20are%20common%20in,mild%20to%20moderate%20to%20severe. 1 in every 5 Americans lives with a mental illness, according to the National Institute of Mental Health.

And that was before the stress and uncertainty of living through a global pandemic.

That’s why the market for treating mental health and neurodegenerative disorders is projected to reach a whopping https://www.globenewswire.com/news-release/2019/07/26/1892319/0/en/Behavioural-Health-Market-Size-to-Hit-US-240-Bn-by-2026.html $240 billion by 2026.

But the transformative medicine movement could be poised to grab a huge share of that market based on early results.

These chemical compounds work in a completely different way than standard medications used today.

While most treatment approaches for mental health tend to focus on treating the symptoms, these compounds take a different approach.

They work by addressing the root cause of the issue by giving you a transformational experience that can help “reset” the brain…

Interrupting the thought patterns and habit loops in the brain that can get people stuck for months or years in many cases.

Read more

This Ancient Aztec Medicine Could Be A Gamechanger For Mental Health

LONDON, Nov. 30, 2020 /PRNewswire/ — Thousands of years ago, ancient Aztecs may have held the key to the next biotech breakthrough. During ceremonial rituals, they used a special compound they called “the flesh of the gods”…And today, researchers are discovering that this same compound could transform mental healthcare moving forward, sparking an explosion of interest in what some experts project could be a $6.9 billion market by 2027.  Mentioned in today’s commentary includes:  Pfizer Inc. (NYSE: PFE), Teva Pharmaceutical Industries Limited (NYSE: TEVA), Johnson & Johnson (NYSE: JNJ), AbbVie Inc. (NYSE: ABBV) Subsdiary Allergan, PLC., Merck & Co., Inc. (NYSE: MRK).

It’s already being studied in some of the top medical facilities in the United States, including Johns Hopkins University, where it was found that this chemical was up to 4x more effective in treating depression than typical antidepressants.

This could become one of the greatest transformations in mental health care we’ve seen in decades, with the potential to treat chronic conditions much faster than typical treatments. And one company plowing ahead at the forefront of this breakthrough is Lobe Sciences Ltd. (LOBE; GTSIF).

The Massive Mental Health Market

In 2019, it was estimated that 1 in every 5 Americans lives with a mental illness, according to the National Institute of Mental Health. And that was before the stress and uncertainty of living through a global pandemic

That’s why the market for treating mental health and neurodegenerative disorders is projected to reach a whopping $240 billion by 2026. But the transformative medicine movement could be poised to grab a huge share of that market based on early results.

A study from Johns Hopkins showed that when treating terminal cancer patients with psychedelics to reduce anxiety and depression, showing an incredible 80% success rate upon administering large doses of Psylocibin. And the FDA has even granted “Breakthrough Therapy” status to various psychedelic clinical trials looking to address treatment-resistant depression. But successfully treating trauma has been a longstanding issue in psychiatry.

Each year, an estimated 8 million Americans suffer from PTSD. That’s more than the population of the entire state of Washington. And with about 1 in every 13 people experiencing post-traumatic stress disorder (PTSD) at some point throughout their lifetime, this is a major priority in the mental health field.

Clearly this all leads to a massive market opportunity, with the alternatives on the market leaving many people continuing to struggle. But Lobe Sciences Ltd. (LOBE; GTSIF) has already assembled ingredients to address the trauma and concussion issues head on. And as they look to play a major role in treating these issues with their solutions, they could stand to grab a huge part of this multi-billion dollar market.

Building A Giant Moat in This Booming Industry

As this industry continues to grow, Lobe Sciences Ltd. (LOBE; GTSIF) is planting its flag and staking its corner of the market. With its recent acquisition of the biotech company Eleusian Biosciences in

Read more